Research Paper Volume 12, Issue 24 pp 26012—26028
Decreased testosterone secretion index and free testosterone level with multiple symptoms for late-onset hypogonadism identification: a nationwide multicenter study with 5980 aging males in China
- 1 Institute of Reproductive Health/Center of Reproductive Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
- 2 Wuhan Tongji Reproductive Medicine Hospital, Wuhan 430013, China
- 3 National Health and Family Planning Key Laboratory of Male Reproductive Health, National Research Institute for Family Planning, Beijing 10081, China
- 4 Department of Andrology, Jinling Hospital, School of Medicine, Nanjing University, Nanjing 210002, China
- 5 School of Public Health, Zunyi Medical University, Zunyi 563006, China
- 6 Guangzhou Women and Children’s Medical Center, Guangzhou 510180, China
- 7 Technical Guidance Institute of Shanxi Province Family Planning Commission, Xi’an 710000, China
- 8 Reproductive Medicine Centre, Peking University International Hospital, Beijing 102206, China
- 9 People’s Hospital of Jinhu, Jinhu 211600, China
- 10 School of Public Health, Guangdong Medical University, Guangzhou 524023, China
- 11 Reproductive Medical Centre, Department of Obstetrics and Gynecology, Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu 610041, China
Received: July 29, 2020 Accepted: September 29, 2020 Published: November 21, 2020
https://doi.org/10.18632/aging.202227How to Cite
Abstract
Late-onset hypogonadism (LOH) is a syndrome in middle-aged and elderly men caused by age-related testosterone deficiency. Age-related change of total testosterone (TT) of Asian males is different from Caucasian population, suggesting difference for LOH identification in Asians. A nationwide cross-sectional study involving six centers in China was conducted. Totally 6296 men aged 40-79 were recruited. After exclusions 5980 men were left for analyses. The serum TT level, was neither decreased with aging nor correlated with most hypogonadal symptoms. Instead, ten hypogonadal symptoms were found to be significantly correlated with free testosterone and testosterone secretion index, thus were chosen to form a concise scale. Further analysis identified a level of free testosterone <210 pmol/L, testosterone secretion index <1.8, and the concise scale score ≧17 could be diagnosed as having significantly aggravated LOH. This study developed an evidence-based criteria for LOH identification in Chinese population and may be adopted in other Asians. It includes the impaired testosterone secretion ability and deficiency of bioavailable testosterone, which should be the main cause in LOH pathogenesis despite normal TT levels, as well as correlated multiple hypogonadal symptoms. Our results may guide the LOH treatment to increase testicular function of testosterone secretion and bioavailable testosterone.